{
  "created_at": "Wed Jul 07 6:30:20 +0000 2021",
  "id_str": "1412652633698062338",
  "full_text": "Data from Israel shows Pfizer’s vaccine protected 64% of inoculated people during an outbreak of the Delta variant, down from 94% before, but retains its potency to prevent severe illness https://t.co/KCMbC44AXd",
  "display_text_range": [
    0,
    211
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/KCMbC44AXd",
        "expanded_url": "https://on.wsj.com/3AKZqwO",
        "display_url": "on.wsj.com/3AKZqwO",
        "indices": [
          188,
          211
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 43,
  "favorite_count": 90,
  "possibly_sensitive": false,
  "original_created_at": "Wed Jul 07 06:00:08 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "イスラエルのデータによると、ファイザー社のワクチンは、デルタ型が発生した際に、接種した人の64％を保護したが、以前の94％に比べて減少した。しかし、重症化を防ぐ力は維持されている。https://t.co/KCMbC44AXd"
    },
    {
      "locale": "zh",
      "full_text": "来自以色列的数据显示，辉瑞公司的疫苗在三角洲变种爆发期间保护了64%的接种者，低于之前的94%，但保留了其预防严重疾病的效力https://t.co/KCMbC44AXd。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "來自以色列的數據顯示，輝瑞公司的疫苗在三角洲變種爆發期間保護了64%的接種者，低於之前的94%，但保留了其預防嚴重疾病的效力https://t.co/KCMbC44AXd。"
    }
  ]
}